Skip to main content

Table 2 Circumstances and toxicology of violence-related deaths reported to a coroner among justice-involved young people

From: Circumstances and toxicology of violence-related deaths among young people who have had contact with the youth justice system: a data linkage study

 

Frequency (n)

Proportion (%)

CIRCUMSTANCES OF DEATH (n = 36)

Events preceding the fatal violent event

  Being involved in a physical or verbal altercation

14

39

  Relationship breakdown or argument with partner

< 5

< 14

  Deceased was involved in a crime

< 5

< 14

  Not reported

15

42

Use of weapon

  Assault with a knife

17

47

  Assault with another weapon

6

17

  Bodily force

6

17

  Firearm

< 5

< 14

  Not reported

6

17

Number of perpetrators of violence

  One

27

75

  Two

< 5

< 14

  Not reported

5

14

Relationship of perpetrator to deceased1

  Friend or acquaintance

8

23

  Current or former intimate partner

8

23

  Stranger/unknown to deceased

5

14

  Family member

< 5

< 14

  Not reported

13

37

Location of violent incident

  Road/street/parking area

14

39

  Other person’s private residence

12

33

  Deceased’s usual place of residence

8

22

  Other (water/commercial area)

< 5

< 14

Day of violent incident

  Friday

9

25

  Sunday

7

19

  Saturday

5

14

  Monday-Thursday

10

28

  Not reported

5

14

TOXICOLOGY (n = 23)

Violence-related deaths with available toxicology reports

23

100

At least one substance detected

22

96

  Cannabis

16

70

  Alcohol

15

65

  Other substances2

10

43

Multiple substances detected

16

70

  Alcohol and cannabis

9

39

  Multiple substances (excluding alcohol)

6

26

  1. 1. Percentages calculated off total number of perpetrators (n = 35). For five decedents no information on the perpetrator of violence were reported. 2. Other substances includes: Benzodiazepines, Morphine, Meth/Amphetamines, Antidepressants, Ketamine, Atropine, Ibuprofen, Lignocaine, Metoclopramide, Paracetamol, Phenytoin, Propofol, Citalopram